Table 3.

All new observed hematological and biochemical toxicity after [¹⁶⁶Ho]-radioembolization during 1 year of follow-up

	CTCAE grade
	Baseline (Pre-[166Ho]-radioembolization)a			0–12 months post-[166Ho]-radioembolization			End of follow-up (1 year)b
	1–2	3	4	1–2	3	4	1–2	3	4
Thrombocyte	8/30			9/31			2/26
Neutrophil				5/31			2/26
Lymphocyte	10/27	5/27		7/31	9/31	1/31	1/26	1/26
Leukocyte	10/30			11/31			5/26
Hemoglobin	6/30			8/31	1/31		4/26

Values are n/available observed patients with the maximum observed toxicity grade during the designated period of follow-up. CTCAE grades at pre-[¹⁶⁶Ho]-radioembolization were counted when the grade was higher than at pre-PRRT, CTCAE grades in post-[¹⁶⁶Ho]-radioembolization follow-up were counted when the grade was higher than at baseline

^aSeveral values not available due to missing data at pre-PRRT

^bFive patients did not reach the 12-month follow-up